Adult Asthma Surveillance and Intervention in a Managed Care Setting

This study has been completed.
Sponsor:
Information provided by:
Kaiser Permanente
ClinicalTrials.gov Identifier:
NCT00147810
First received: September 2, 2005
Last updated: March 23, 2006
Last verified: September 2005
  Purpose
  1. To determine if there are gender differences in asthma prevalence, severity, treatment, and health care utilization within patient populations in Kaiser Permanente Northwest and Colorado Regions.
  2. To test the ability of an automated telephone outreach intervention to reduce health care utilization for acute asthma exacerbations and improve quality of life. The intervention used speech recognition technology to gather information about current asthma control, patterns of medication use, and recent acute health care utilization for asthma. This information allowed the intervention to provide tailored educational feedback and to flag patients deemed to be at high risk for future exacerbations so that they could be followed up by the health care system.

Condition Intervention
Asthma
Procedure: Telephone outreach to enhance asthma care

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Adult Asthma Surveillance and Intervention in a Managed Care Setting

Resource links provided by NLM:


Further study details as provided by Kaiser Permanente:

Primary Outcome Measures:
  • health status
  • current asthma control
  • patterns of medication use
  • asthma quality of life
  • self-management practices
  • attitudes about asthma
  • satisfaction with care
  • health care utilization
  • dispensings of anti-asthma medications
  • routine and acute health care utilization

Secondary Outcome Measures:
  • patient satisfaction
  • clinician satisfaction

Estimated Enrollment: 6948
Study Start Date: November 2001
Estimated Study Completion Date: July 2004
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • 18 years or older
  • On KPNW high-risk asthma registry
  • At least 180 days of asthma medications dispensings
  • At least one visit for asthma in previous 2 years

Exclusion Criteria:

  • Diagnosis of COPD on problem list in electronic medical record
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00147810

Locations
United States, Oregon
Kaiser Permanente Center for Health Research
Portland, Oregon, United States, 97227
Sponsors and Collaborators
Kaiser Permanente
Investigators
Principal Investigator: William M Vollmer, PhD Kaiser Permanente
  More Information

Additional Information:
Publications:

ClinicalTrials.gov Identifier: NCT00147810     History of Changes
Other Study ID Numbers: CASHEW 200-95-0953-48, CDC/ACHP 200-95-0953-48
Study First Received: September 2, 2005
Last Updated: March 23, 2006
Health Authority: United States: Institutional Review Board

Keywords provided by Kaiser Permanente:
telephone outreach
asthma care

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on August 26, 2014